Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #1830 on Enanta Pharmaceuticals Inc (ENTA)
DewDiligence
01/13/20 5:45 PM
#1831 RE: DewDiligence #1830
We are also introducing today our newest program, which is for treatment of hMPV, a pathogen identified in 2001 that causes upper and lower respiratory tract infections in young children and the elderly, as well as COPD, asthma, and immunocompromised patients.
01/13/20 6:03 PM
#1832 RE: DewDiligence #1830